أوبنهايمر تحافظ على تفوقها على InflaRx، وتخفض السعر المستهدف إلى 3 دولارات

InflaRx -2.85%

InflaRx

IFRX

0.99

-2.85%

Oppenheimer analyst Andreas Argyrides maintains InflaRx (NASDAQ: IFRX) with a Outperform and lowers the price target from $6 to $3.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via